US2010135461A1PendingUtilityA1
Biometric diagnosis
Est. expiryJan 12, 2027(~0.5 yrs left)· nominal 20-yr term from priority
Inventors:Veronica James
A61B 6/4092G01N 23/20A61B 6/483G01N 2223/612A61B 6/508G01N 33/483A61B 6/48
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a method of detecting neoplastic or neurological disorders comprising exposing skin or nails to X-ray diffraction and detecting changes in the ultrastructure of the skin or nails, and also provides an instrument when used in the method of detection.
Claims
exact text as granted — not AI-modified1 . A method of detecting neoplastic or neurological disorders in a subject, the method comprising exposing biological material of the subject to fibre X-ray diffraction, and detecting changes in the ultrastructure of the biological material, wherein the biological material is a skin or nail sample, and wherein when the biological material is a skin sample, the neoplastic disorder is not BRAC1-related breast cancer.
2 . The method of claim 1 , wherein the X-rays are derived from an X-ray source with energies between 5 and 25 keV and wavelengths between 0.06 and 0.20 nm.
3 . The method of claim 2 , wherein the source is a low-angle synchrotron facility.
4 . The method of claim 1 , wherein the biological material is a skin sample and the neoplastic disorder is prostate cancer or BRCA1-unrelated breast cancer.
5 . The method of claim 1 , wherein the biological material is a nail sample and the neoplastic disorder is breast cancer or colon cancer.
6 . The method of claim 1 , wherein the biological material is a nail sample and the neurological disorder is Alzheimer's disease.
7 . An instrument when used in the method of claim 1 , the instrument comprising: an X-ray source producing a beam of X-radiation; a sample stage for positioning the biological sample within the beam; a detector for detecting scattering of the X-ray beam; and a display means associated with the detector for displaying the output of the detector; whereby patterns of output related to the presence of the disorder are displayed for interpretation.
8 . The instrument of claim 7 , wherein the X-rays are derived from a monochromatic X-ray source with energies between 5 and 25 keV and wavelengths between 0.06 and 0.20 nm.
9 . The instrument of claim 8 , wherein the source is a low-angle synchrotron facility.Join the waitlist — get patent alerts
Track US2010135461A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.